Cargando…

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

Inappropriate localization of proteins can interfere with normal cellular function and drive tumor development. To understand how this contributes to the development of acute myeloid leukemia (AML), we compared the nuclear proteome and transcriptome of AML blasts with normal human CD34(+) cells. Ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alanazi, Bader, Munje, Chinmay R., Rastogi, Namrata, Williamson, Andrew J. K., Taylor, Samuel, Hole, Paul S., Hodges, Marie, Doyle, Michelle, Baker, Sarah, Gilkes, Amanda F., Knapper, Steven, Pierce, Andrew, Whetton, Anthony D., Darley, Richard L., Tonks, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995695/ https://www.ncbi.nlm.nih.gov/pubmed/31611628 http://dx.doi.org/10.1038/s41375-019-0596-4

Ejemplares similares

Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia
por: Rastogi, Namrata, et al.
Publicado: (2022)

Use of an anti‐CD200‐blocking antibody improves immune responses to AML in vitro and in vivo
por: Rastogi, Namrata, et al.
Publicado: (2020)

Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux
por: Nicholson, Rachael, et al.
Publicado: (2022)

Increased expression of RUNX3 inhibits normal human myeloid development
por: Menezes, Ana Catarina, et al.
Publicado: (2022)

Reactive Oxygen Species Rewires Metabolic Activity in Acute Myeloid Leukemia
por: Robinson, Andrew J., et al.
Publicado: (2021)

THOC5 controls 3′end-processing of immediate early genes via interaction with polyadenylation specific factor 100 (CPSF100)
por: Tran, Doan Duy Hai, et al.
Publicado: (2014)

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells
por: Pearson, Stella, et al.
Publicado: (2022)

γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin
por: Morgan, R G, et al.
Publicado: (2013)

RUNX1–ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1
por: Liddiard, K, et al.
Publicado: (2012)

Reactive oxygen species in leukemias: maintaining cancer cell proliferation via redox signaling and changing metabolic homeostasis
por: Robinson, Andrew J., et al.
Publicado: (2021)

LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells
por: Morgan, Rhys G., et al.
Publicado: (2019)

RUNX3 overexpression inhibits normal human erythroid development
por: Menezes, Ana Catarina, et al.
Publicado: (2022)

A Novel Therapeutic Strategy for the Treatment of Glioma, Combining Chemical and Molecular Targeting of Hsp90α
por: Mehta, Adi, et al.
Publicado: (2011)

Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches
por: Pearson, S, et al.
Publicado: (2017)

Erratum: Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches
por: Pearson, S, et al.
Publicado: (2017)

Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3(+) regulatory T cells
por: Coles, S J, et al.
Publicado: (2012)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Expression of CD33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia
por: Khan, Naeem, et al.
Publicado: (2016)

Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2012)

Correction: Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2013)

S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL
por: Knapper, Steven, et al.
Publicado: (2023)

S100 Proteins in Acute Myeloid Leukemia()()
por: Brenner, Annette K., et al.
Publicado: (2018)

Crosstalk between b-catenin and WT1 signaling activity in acute myeloid leukemia
por: Wagstaff, Megan, et al.
Publicado: (2022)

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients
por: Dennis, Mike, et al.
Publicado: (2021)

Proteomic Analysis of an Induced Pluripotent Stem Cell Model Reveals Strategies to Treat Juvenile Myelomonocytic Leukemia
por: Pearson, Stella, et al.
Publicado: (2019)

Proteomic Biomarkers for the Detection of Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2019)

The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
por: Pellicano, Francesca, et al.
Publicado: (2014)

Oncogenic MYC amplifies mitotic perturbations
por: Littler, Samantha, et al.
Publicado: (2019)

AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells
por: Pearson, Stella, et al.
Publicado: (2019)

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia
por: Khan, Naeem, et al.
Publicado: (2016)

Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women
por: Njoku, Kelechi, et al.
Publicado: (2023)

Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010)

Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease
por: Whetton, Anthony D., et al.
Publicado: (2020)

MPL W515L expression induces TGFβ secretion and leads to an increase in chemokinesis via phosphorylation of THOC5
por: Whetton, Anthony D., et al.
Publicado: (2016)

CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
por: Kinstrie, Ross, et al.
Publicado: (2020)

Retrospective Proteomic Screening of 100 Breast Cancer Tissues
por: Pucci-Minafra, Ida, et al.
Publicado: (2017)

Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
por: Kinstrie, Ross, et al.
Publicado: (2020)

Broadening the Socio-Technical Horizons of Health Informatics
por: Georgiou, Andrew, et al.
Publicado: (2010)

Conceptual Challenges for Advancing the Socio-Technical Underpinnings of Health Informatics
por: Whetton, Sue, et al.
Publicado: (2010)

Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8jqh4b0bigvodi9e16q89b76m4